戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ts, flow cytometry, histologic analysis, and immunohistochemical analysis.
2               Thirty-seven samples underwent immunohistochemical analysis.
3 nstrated by ELISA for TIE-2 in lysates or by immunohistochemical analysis.
4 t cytopathological examination that included immunohistochemical analysis.
5 o underwent cardiac surgery and subjected to immunohistochemical analysis.
6 ellular accumulation of these proteins using immunohistochemical analysis.
7 mine due to lack of validated antibodies for immunohistochemical analysis.
8 ll as the sensitivity and specificity of VE1 immunohistochemical analysis.
9 ve data requires further studies with modern immunohistochemical analysis.
10 ins of the most abundantly detected virus by immunohistochemical analysis.
11 d or soluble fibrillar Abeta by quantitative immunohistochemical analysis.
12 l biopsies were taken for mRNA, protein, and immunohistochemical analysis.
13 protein expression, immunoprecipitation, and immunohistochemical analysis.
14 in an animal model of brain tumor along with immunohistochemical analysis.
15 ze with the novel arm prior to sacrifice and immunohistochemical analysis.
16 ymerase chain reaction and validated through immunohistochemical analysis.
17 of the affected cats by Western blotting and immunohistochemical analysis.
18 uled removal of the implant and prepared for immunohistochemical analysis.
19 ans of a polymerase-chain-reaction assay and immunohistochemical analysis.
20  translation to their respective proteins by immunohistochemical analysis.
21 bone metastasis as determined by qRT-PCR and immunohistochemical analysis.
22 relaxometry in both models were confirmed at immunohistochemical analysis.
23 therapy from 192 patients were available for immunohistochemical analysis.
24 examined using mouse periodontium tissues by immunohistochemical analysis.
25 ival tissues was also assessed using in situ immunohistochemical analysis.
26 ity, rapid solidification, and its impact on immunohistochemical analysis.
27           Expression of TrkA was explored by immunohistochemical analysis.
28                                  By means of immunohistochemical analysis, all GIST cells expressed C
29                                              Immunohistochemical analysis also revealed higher chondr
30                                              Immunohistochemical analysis also showed significant red
31                                              Immunohistochemical analysis also showed that p27 was mi
32                                              Immunohistochemical analysis also suggested that CDCP1 i
33  retina whole mounts, we combined structural immunohistochemical analysis and a functional assessment
34 nt testing for expression and integration by immunohistochemical analysis and blue native polyacrylam
35     Vascularization in CIA was determined by immunohistochemical analysis and determination of cytoki
36                                   Through an immunohistochemical analysis and flow cytometry-based ap
37                                              Immunohistochemical analysis and fluorescence in situ hy
38                                              Immunohistochemical analysis and immunofluorescent micro
39                                              Immunohistochemical analysis and immunofluorescent micro
40 rease in mice were characterized by means of immunohistochemical analysis and transmission electron m
41 , including classification, histological and immunohistochemical analysis, and donor- specific antibo
42 re collected and analyzed by histopathology, immunohistochemical analysis, and immunoblot analysis; w
43  and placental maternal mononuclear cells by immunohistochemical analysis, and no antigen was seen in
44 4 primary tumors and 76 metastases) with VE1 immunohistochemical analysis, and results were compared
45         Adjacent sections were processed for immunohistochemical analysis (as needed) using the follo
46 ever, the immune phenotype, as determined by immunohistochemical analysis, cannot discriminate betwee
47                                              Immunohistochemical analysis confirmed ABCB1 induction i
48                                              Immunohistochemical analysis confirmed ABCB1 induction i
49 ost notably CXCR5 and its ligand CXCL13, and immunohistochemical analysis confirmed CXCR5 expression,
50                                              Immunohistochemical analysis confirmed enhanced expressi
51                                              Immunohistochemical analysis confirmed increased express
52                                              Immunohistochemical analysis confirmed localization of A
53                                              Immunohistochemical analysis confirmed that PTK7 is high
54                     Second, western blot and immunohistochemical analysis confirmed that Sal-1 suppre
55                                              Immunohistochemical analysis confirmed that sensory fibe
56                                              Immunohistochemical analysis confirmed the presence of p
57                                              Immunohistochemical analysis confirms increased extracel
58                                              Immunohistochemical analysis correctly identified 13 of
59                           Hence, its routine immunohistochemical analysis could be used clinically to
60                                              Immunohistochemical analysis demonstrated colocalization
61  9 patients at 4 tertiary care institutions, immunohistochemical analysis demonstrated strong CD31/PE
62                                              Immunohistochemical analysis demonstrated that the inhib
63                                              Immunohistochemical analysis demonstrated that TrkC-posi
64                                              Immunohistochemical analysis demonstrated that YC-1 + GI
65  revealed vascular leakage in cbs(-/-) mice; immunohistochemical analysis demonstrated vascular patte
66                     Expression profiling and immunohistochemical analysis detected upregulated expres
67                                              Immunohistochemical analysis documented early abnormalit
68  on periodontium using histomorphometric and immunohistochemical analysis during and after experiment
69 -operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well
70                                              Immunohistochemical analysis for ER and progesterone rec
71 rentiation of recombinants was determined by immunohistochemical analysis for expression of the basal
72 med, followed by biodistribution studies and immunohistochemical analysis for gal-3 and NIS expressio
73                     Tumors were subjected to immunohistochemical analysis for immune checkpoints (PD-
74                                              Immunohistochemical analysis for nuclear factor of activ
75 ge to differ according to race, we performed immunohistochemical analysis for proteins mechanisticall
76 surgical specimens were also investigated by immunohistochemical analysis for the presence of inflamm
77                            Muscle biopsy and immunohistochemical analysis found deficiencies of lamin
78  and protein levels (by western blotting and immunohistochemical analysis) from the same samples.
79 grammed cell death 1 ligand 1) expression by immunohistochemical analysis has been used as a predicti
80 grammed cell death 1 ligand 1) expression by immunohistochemical analysis has been used as a predicti
81  Outcomes were HPV status as measured by p16 immunohistochemical analysis, HPV16 DNA in situ hybridiz
82  Outcomes were HPV status as measured by p16 immunohistochemical analysis, HPV16 DNA in situ hybridiz
83                                              Immunohistochemical analysis identified a selective redu
84                                      PCR and immunohistochemical analysis identified the presence of
85                 Tumors were characterized by immunohistochemical analysis (IHC) for succinate dehydro
86 her culture systems using techniques such as immunohistochemical analysis (IHC), western blotting and
87 on of S1P1 in the LPS model was confirmed by immunohistochemical analysis (IHC).
88 t generation sequencing, protein expression (immunohistochemical analysis [IHC]), and gene amplificat
89 oduced in the developing and adult pancreas, immunohistochemical analysis illustrated a broad Ldb1 pr
90                                           An immunohistochemical analysis in 2 and 10 mg/kg KA-induce
91 l of expression of ERCC1 protein by means of immunohistochemical analysis in a validation set of samp
92                            Validation of VE1 immunohistochemical analysis in clinical practice is nee
93 ils were observed by electron microscopy and immunohistochemical analysis in the exocrine pancreas of
94        Gene expression studies combined with immunohistochemical analysis in the kidney showed that P
95                                              Immunohistochemical analysis indicated macrophages adjac
96                                              Immunohistochemical analysis indicated that DOX-HK-MPEG-
97                                              Immunohistochemical analysis indicates that hyperactivat
98 andardization, and prediction of response by immunohistochemical analysis is additionally limited by
99                                 We performed immunohistochemical analysis, knockdown and overexpressi
100                                              Immunohistochemical analysis localized CSE to smooth mus
101                                              Immunohistochemical analysis localized each protein to m
102 0E mutation-specific monoclonal antibody VE1 immunohistochemical analysis may facilitate rapid detect
103 ngs were studied with the use of seven-color immunohistochemical analysis, micro-computed tomographic
104 eers using quantitative noninvasive devices, immunohistochemical analysis, mRNA sequencing, and quant
105                                              Immunohistochemical analysis of 15 tumors showed that pu
106                                     By using immunohistochemical analysis of 162 prostate cancer tiss
107                                 We conducted immunohistochemical analysis of 2,394 patient specimens
108                                              Immunohistochemical analysis of 230 primary endometrial
109 d over an independent set of 368 ICCs and by immunohistochemical analysis of 64 ICC tissue samples.
110 esponder profiles were identified through an immunohistochemical analysis of a chordoma tissue bank o
111                                              Immunohistochemical analysis of a cohort of non-small-ce
112                                              Immunohistochemical analysis of a collection of human br
113                               In this study, immunohistochemical analysis of a human breast TMA showe
114 e, histopathologic analysis, and comparative immunohistochemical analysis of a range of cytokeratins
115  of the PET scans, brains were harvested for immunohistochemical analysis of ABCB1 and AB levels.
116  of the PET scans, brains were harvested for immunohistochemical analysis of ABCB1 and Abeta levels.
117 by targeted resequencing, miRNA analysis and immunohistochemical analysis of additional tumors.
118                                              Immunohistochemical analysis of AMPAR subunits in mature
119                                              Immunohistochemical analysis of Bim expression demonstra
120                                              Immunohistochemical analysis of biopsies from patients w
121 avbeta6 integrin levels in the lung requires immunohistochemical analysis of biopsy samples.
122                                              Immunohistochemical analysis of blood smears revealed th
123                                Retrospective immunohistochemical analysis of bone marrow specimens fr
124 and elastin in the infarct (P<0.05), whereas immunohistochemical analysis of borderzone myocardium sh
125                                              Immunohistochemical analysis of brain tissue and dura re
126                                              Immunohistochemical analysis of brain tissue from two CY
127  epithelial brushings, pathway analysis, and immunohistochemical analysis of bronchial biopsy specime
128                    The idea emerged from the immunohistochemical analysis of carbonic anhydrases (CA)
129                                           On immunohistochemical analysis of CD177 in human advanced
130                                              Immunohistochemical analysis of CD177, one of the up-reg
131                                              Immunohistochemical analysis of chronic pancreatitis (CP
132                                              Immunohistochemical analysis of Claudin-2 and/or Afadin
133                                Consistently, immunohistochemical analysis of clinical breast tumor ti
134 men bleaching, as the standard substrate for immunohistochemical analysis of conjunctival MLs.
135                                              Immunohistochemical analysis of coronary artery plaque w
136                                              Immunohistochemical analysis of cSCC tissue sections and
137                                              Immunohistochemical analysis of ears from immunized/chal
138 , by measuring striatal neuronal activation (immunohistochemical analysis of ERK1/2 phosphorylation)
139                                              Immunohistochemical analysis of FLNC localization in car
140 allow for hematoxylin and eosin staining and immunohistochemical analysis of formalin-fixed, paraffin
141                                              Immunohistochemical analysis of GBM samples revealed inc
142 u]-LLP2A uptake than uninfected tissues, and immunohistochemical analysis of granulomas with known [(
143                     Finally, a comprehensive immunohistochemical analysis of GRHL2 expression in prim
144 n, and dosimetry studies in mice, as well as immunohistochemical analysis of harvested tumors, were p
145                                  Exploratory immunohistochemical analysis of HLA-DRA and BTNL2 expres
146                                              Immunohistochemical analysis of HNSCC tumor arrays showe
147                                  Lineage and immunohistochemical analysis of Hoxc8 in mice revealed t
148                                              Immunohistochemical analysis of human carotid plaques an
149 enin signaling in EOC has been reported, and immunohistochemical analysis of human EOC tumors demonst
150                              We combined the immunohistochemical analysis of human IPF biopsy materia
151          These data are further supported by immunohistochemical analysis of human NSCLC samples show
152 h phage display-based functional proteomics, immunohistochemical analysis of human pancreatic ductal
153                                              Immunohistochemical analysis of human PCa tissues reveal
154                             Western blot and immunohistochemical analysis of human post-mortem substa
155                                              Immunohistochemical analysis of human small bowel tissue
156                                              Immunohistochemical analysis of human specimens (n = 198
157                                              Immunohistochemical analysis of Ki67 and cleaved caspase
158                                              Immunohistochemical analysis of kidney specimens using d
159                                              Immunohistochemical analysis of KS expression was perfor
160          We examined periostin expression by immunohistochemical analysis of lesional and nonlesional
161                                              Immunohistochemical analysis of liver from the one BASM
162                                  Clinically, immunohistochemical analysis of liver metastases from ch
163    This result was subsequently confirmed by immunohistochemical analysis of MCAM and LAMA4 expressio
164                                              Immunohistochemical analysis of mouse cerebellar tissue
165 ng histopathological analysis, including the immunohistochemical analysis of MUC (ie, MUC1, MUC2, and
166 ing the traditional approaches of histology, immunohistochemical analysis of muscle biopsy, and candi
167                             Western blot and immunohistochemical analysis of muscle from the proband
168                                              Immunohistochemical analysis of normal breast tissue rev
169                                     Further, immunohistochemical analysis of NPC tumor tissues reveal
170                                              Immunohistochemical analysis of OSCC tumors that develop
171                                    Moreover, immunohistochemical analysis of paired lung tissues show
172                                              Immunohistochemical analysis of paired tumor biopsies re
173            Disease severity was measured via immunohistochemical analysis of pancreata measuring loss
174       Up-regulation in PDAC was validated by immunohistochemical analysis of pancreatic tissue sample
175                                              Immunohistochemical analysis of patient tumor samples re
176 ted in PDAC, which was also confirmed by our immunohistochemical analysis of PDAC tissue microarray.
177                                              Immunohistochemical analysis of phosphorylated FRS2 prot
178                                              Immunohistochemical analysis of phosphorylated, active M
179                            We also performed immunohistochemical analysis of PPARD levels in 2 sets o
180                                              Immunohistochemical analysis of pretreatment marrow reve
181 n significantly reduced tumor growth in vivo Immunohistochemical analysis of primary human melanomas
182                                     Finally, immunohistochemical analysis of prostate cancer tissue i
183                                              Immunohistochemical analysis of prostate cancer tissue m
184                                Molecular and immunohistochemical analysis of renal function, tissue d
185                                              Immunohistochemical analysis of retinal tissue from pati
186                              Furthermore, an immunohistochemical analysis of SNAI2 in archived primar
187                                              Immunohistochemical analysis of specimens from 59 patien
188                                              Immunohistochemical analysis of spleen sections from wil
189 ettsial species in tick salivary glands, and immunohistochemical analysis of the attachment site iden
190                                              Immunohistochemical analysis of the developing molars sh
191 e wound area was subjected to histologic and immunohistochemical analysis of the epithelial gap, numb
192                                     However, immunohistochemical analysis of the kidneys of mice trea
193 bin, leukocytes, platelets, creatinine), and immunohistochemical analysis of the kidneys.
194                                              Immunohistochemical analysis of the MAP2K1 downstream ta
195                                              Immunohistochemical analysis of the mouse brain revealed
196  confirmed with nerve conduction studies and immunohistochemical analysis of the neuromuscular juncti
197 ospho-p38, and phospho-ERK or were fixed for immunohistochemical analysis of the nuclear translocatio
198                                              Immunohistochemical analysis of the p50 and c-Rel subuni
199                      In addition, results of immunohistochemical analysis of the perilesional skin re
200                                              Immunohistochemical analysis of the retina revealed that
201                                              Immunohistochemical analysis of the tumorous lungs showe
202                                              Immunohistochemical analysis of the xenograft further de
203                                              Immunohistochemical analysis of the xenograft tissues re
204                                              Immunohistochemical analysis of these cases and addition
205                                              Immunohistochemical analysis of these demonstrated the i
206                             Western blot and immunohistochemical analysis of tissue from temporal lob
207                                              Immunohistochemical analysis of tissue microarrays confi
208                                              Immunohistochemical analysis of tumor specimens from sta
209                                              Immunohistochemical analysis of tumor vascular and cell
210                                              Immunohistochemical analysis of untreated tumors confirm
211                                           An immunohistochemical analysis of zebrafish revealed that
212                                      Further immunohistochemical analysis on 42 breast carcinoma spec
213 orrelated with MR imaging and histologic and immunohistochemical analysis on a prostate-segment (12 r
214 rcoma; documented loss of INI1 expression by immunohistochemical analysis or biallelic SMARCB1 (the g
215 iagnostic assays, including molecular tests, immunohistochemical analysis, pathologic analysis, and e
216 detected in nontumor tissues, which, through immunohistochemical analysis, proved positive for integr
217 lasts were measured through radiographic and immunohistochemical analysis, respectively.
218                                              Immunohistochemical analysis revealed a reduction in apo
219                                              Immunohistochemical analysis revealed a significant redu
220                                              Immunohistochemical analysis revealed cytoplasmatic and
221                                              Immunohistochemical analysis revealed decreased numbers
222                                              Immunohistochemical analysis revealed enhanced staining
223                                              Immunohistochemical analysis revealed expression of andr
224                                              Immunohistochemical analysis revealed expression of cyto
225                                              Immunohistochemical analysis revealed extensive expressi
226                                              Immunohistochemical analysis revealed frequent overexpre
227                                              Immunohistochemical analysis revealed higher numbers of
228                                              Immunohistochemical analysis revealed mature neuronal pa
229                                              Immunohistochemical analysis revealed microglial or macr
230                                              Immunohistochemical analysis revealed multiple inclusion
231                                              Immunohistochemical analysis revealed perivascular, neur
232                                              Immunohistochemical analysis revealed RAC expression and
233                                              Immunohistochemical analysis revealed regional differenc
234                                              Immunohistochemical analysis revealed rhythmic expressio
235                                              Immunohistochemical analysis revealed significant increa
236                                              Immunohistochemical analysis revealed smaller beta-cell
237                                     Finally, immunohistochemical analysis revealed strong expression
238    Ex vivo patch clamp electrophysiology and immunohistochemical analysis revealed that alpha-klotho
239                                              Immunohistochemical analysis revealed that compared to s
240                     MRI, histopathology, and immunohistochemical analysis revealed that dietary isorh
241                                     Finally, immunohistochemical analysis revealed that MSCs were fou
242 ical NF-kappaB signaling, including NIK, and immunohistochemical analysis revealed that NIK was almos
243                      At the molecular level, immunohistochemical analysis revealed that SP supplement
244                                              Immunohistochemical analysis revealed that the amount of
245                                              Immunohistochemical analysis revealed that the expressio
246                                              Immunohistochemical analysis revealed that the Rac activ
247 ate possible routes of HPFv GLP-1 signaling, immunohistochemical analysis revealed the absence of GLP
248 AP in the liver and cisplatin in the kidney, immunohistochemical analysis revealed the elevated expre
249  absence of particular K(ir)2.x isoforms, as immunohistochemical analysis revealed the expression of
250                                              Immunohistochemical analysis revealed upregulated tubula
251                        In the present study, immunohistochemical analysis reveals a spatiotemporal ex
252                                              Immunohistochemical analysis reveals a strong positive c
253                                              Immunohistochemical analysis reveals neoplastic cells th
254 R2-enriched subtype, ESR1, treatment arm, ER immunohistochemical analysis scores, Genomic Grade Index
255                                              Immunohistochemical analysis should be investigated furt
256                                              Immunohistochemical analysis showed a significantly high
257 ptosis pathway in this protective effect and immunohistochemical analysis showed an antibody uptake i
258                                              Immunohistochemical analysis showed colocalization of ci
259                                              Immunohistochemical analysis showed DRAM2 localization t
260                                              Immunohistochemical analysis showed enhanced leptin and
261                                              Immunohistochemical analysis showed markedly reduced CD3
262                                              Immunohistochemical analysis showed prodynorphin content
263                                          The immunohistochemical analysis showed significantly increa
264                                              Immunohistochemical analysis showed specific cytoplasmic
265                                              Immunohistochemical analysis showed specific expression
266               In accordance with these data, immunohistochemical analysis showed that both leukotrien
267                                              Immunohistochemical analysis showed that Hic-5 is primar
268                                              Immunohistochemical analysis showed that IL-17C expressi
269                                              Immunohistochemical analysis showed that the neovessels
270                                              Immunohistochemical analysis showed that TRAF1 expressio
271        Consistent with this regulatory role, immunohistochemical analysis shows co-expression of WT1
272 ted in breast malignancies by microarray and immunohistochemical analysis, so we hypothesized that (1
273                                              Immunohistochemical analysis substantiated that Galectin
274                              As confirmed by immunohistochemical analysis, the proliferative cell pop
275                                 We found VE1 immunohistochemical analysis to be a useful and rapid as
276                         Here we use detailed immunohistochemical analysis to document the expression
277                                              Immunohistochemical analysis using an antibody specific
278 sis is possible with cytopathologic exam and immunohistochemical analysis using ultrasound-guided FNA
279                          Presence of VEGF by immunohistochemical analysis (VEGF protein) and in situ
280                                              Immunohistochemical analysis was also performed to estim
281              Hematoxylin and eosin (H&E) and immunohistochemical analysis was conducted.
282                                 Furthermore, immunohistochemical analysis was performed on surgical b
283 ematoxylin-eosin (H&E)-stained sections, and immunohistochemical analysis was performed to assess CD8
284                                              Immunohistochemical analysis was performed to detect the
285                                              Immunohistochemical analysis was performed using anti-ES
286                                              Immunohistochemical analysis was performed.
287                                              Immunohistochemical analysis was positive for estrogen a
288                                Glycophorin C immunohistochemical analysis was useful to differentiate
289                                      Through immunohistochemical analysis, we detected SLIT2 receptor
290            Here, through neuroanatomical and immunohistochemical analysis, we identified, in the crab
291                            Based on detailed immunohistochemical analysis, we postulated the recipien
292 e overall sensitivity and specificity of VE1 immunohistochemical analysis were 96.7% and 94.5%, respe
293 l history or tissue available for review and immunohistochemical analysis were excluded.
294 t findings between DNA mutation analysis and immunohistochemical analysis were observed in 12 tumors.
295 lysis for BRAF splicing, RNA sequencing, and immunohistochemical analysis were performed on tumor sam
296 lveolar bone level, and attachment loss, and immunohistochemical analysis, which included immunoreact
297  resected pancreatic adenocarcinoma (PAC) by immunohistochemical analysis with clinical outcome.
298                                              Immunohistochemical analysis with the use of currently a
299 ssed PD-L1 expression in tumor samples using immunohistochemical analysis, with results reported as t
300 nstability and/or absence of MMR proteins in immunohistochemical analysis, without hypermethylation o

 
Page Top